Subsequent studies demonstrated that the oncogenic EGFRvIII from human squamous cell carcinoma cells was transferred via extracellular vesicles to tumor-associated endothelial cells to activate MAPK and Akt cell signaling pathways and promote endothelial VEGF expression (Al-Nedawi et al., 2009b). This evidence concerns the gene VEGFA and neoplasm.